1. Home
  2. CLSD vs PHUN Comparison

CLSD vs PHUN Comparison

Compare CLSD & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • PHUN
  • Stock Information
  • Founded
  • CLSD 2011
  • PHUN 2009
  • Country
  • CLSD United States
  • PHUN United States
  • Employees
  • CLSD N/A
  • PHUN N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • PHUN EDP Services
  • Sector
  • CLSD Health Care
  • PHUN Technology
  • Exchange
  • CLSD Nasdaq
  • PHUN Nasdaq
  • Market Cap
  • CLSD 69.0M
  • PHUN 58.3M
  • IPO Year
  • CLSD 2016
  • PHUN N/A
  • Fundamental
  • Price
  • CLSD $0.76
  • PHUN $2.97
  • Analyst Decision
  • CLSD Strong Buy
  • PHUN Buy
  • Analyst Count
  • CLSD 5
  • PHUN 2
  • Target Price
  • CLSD $4.80
  • PHUN $7.50
  • AVG Volume (30 Days)
  • CLSD 161.6K
  • PHUN 192.4K
  • Earning Date
  • CLSD 05-14-2025
  • PHUN 05-12-2025
  • Dividend Yield
  • CLSD N/A
  • PHUN N/A
  • EPS Growth
  • CLSD N/A
  • PHUN N/A
  • EPS
  • CLSD N/A
  • PHUN N/A
  • Revenue
  • CLSD $3,764,000.00
  • PHUN $2,956,000.00
  • Revenue This Year
  • CLSD N/A
  • PHUN $10.47
  • Revenue Next Year
  • CLSD $476.77
  • PHUN $53.56
  • P/E Ratio
  • CLSD N/A
  • PHUN N/A
  • Revenue Growth
  • CLSD N/A
  • PHUN N/A
  • 52 Week Low
  • CLSD $0.70
  • PHUN $2.22
  • 52 Week High
  • CLSD $1.65
  • PHUN $14.60
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 34.26
  • PHUN 48.94
  • Support Level
  • CLSD $0.77
  • PHUN $2.86
  • Resistance Level
  • CLSD $0.91
  • PHUN $3.18
  • Average True Range (ATR)
  • CLSD 0.06
  • PHUN 0.14
  • MACD
  • CLSD -0.01
  • PHUN -0.01
  • Stochastic Oscillator
  • CLSD 5.82
  • PHUN 34.13

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.

Share on Social Networks: